Marijuana Business Magazine November-December 2019

Israeli Distribution Agreement Israel-based InterCure entered into a strategic distribution agreement with Salomon, Levin & Elstein (SLE), which is owned by Teva Pharmaceutical Industries . Under terms of the agreement, SLE will distribute products by Canndoc , a wholly owned subsidiary of InterCure, to pharma clients such as hospitals, health maintenance organizations and pharmacies in Israel. In the future, as regulatory approvals allow, SLE will provide logistics capability for exporting Canndoc’s products to countries that support regulations for the sale and distribution of cannabis goods for medical use. The distribution agreement is set for a three-year term and includes a mechanism for automatic extension periods of two years each. EU Approves GW’s Epilepsy Drug The European Commission granted marketing authorization to Epidyolex, the trade name in the European Union for Epidiolex, a cannabis-based epilepsy drug produced by GW Pharmaceuticals of the United Kingdom. In June 2018, the U.S. Food and Drug Administration approved Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients age 2 and older. Note: Entries sourced from Marijuana Business Daily, Hemp Industry Daily and other international, national and local news outlets. These developments occurred before this magazine’s publication deadline, so some situations may have changed. INTERNATIONAL DEVELOPMENTS Largest Cannabis, CBD & Hemp Testing Laboratory in the Southeastern USA. Awarded 14 Emerald Test Badges for Spring 2019. Most Awards In the Eastern United States. MEDICAL GRADE TESTING • RELIABLE RESULTS • RESULTS IN 2-5 DAYS • COMPETITIVE RATES 888-407-6675 • ACSLABCANNABIS.COM • TAMPA, FL 33573